Limb-sparing treatment for canine osteosarcoma to be explored in new studyNovember 14, 2023The new research is set to evaluate the effectiveness of a novel drug combination tailored to giant-breed dogs diagnosed with osteosarcoma.
SPONSORED CONTENTA Modern Approach to Parasite PreventionWith evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection. + Learn More
AI aids in precision treatment for cancerSeptember 28, 2023This year, approximately six million dogs will be diagnosed with cancer. Although the incidence of canine cancer is nearly three times higher than human cancer, veterinarians have far fewer tools at their disposal to effectively treat their patients.
Controlling tumor growth target of cancer trialAugust 18, 2023 Improving outcomes for dogs afflicted with a particularly aggressive and fatal type of cancer is the goal of a clinical trial currently underway. A newly funded study will evaluate the potential of a cancer drug to control tumor growth for dogs with histiocytic sarcoma. The multi-center clinical trial, which is being conducted at Michigan State University (MSU), University of Florida, University of Wisconsin, and Virginia Tech, will be funded by the Bernese Mountain Dog Club of America (BMDCA) through Morris Animal Foundation's Donor-Inspired Study program. Histiocytic sarcoma was first described in Bernese mountain dogs in the late 1970s, but has since been noted in many other breeds, Morris Animal Foundation reports. "Histiocytic sarcoma is a devastating disease, and traditional chemotherapeutic drugs have shown limited success in improving treatment outcomes, especially with the disseminated form of the disease," says the study's principal investigator, Vilma Yuzbasiyan-Gurkan, PhD, a professor of microbiology, molecular genetics, and small animal clinical sciences at MSU. "Based on our studies of the molecular pathways driving tumor growth, we now have an opportunity to use a targeted approach in …
Canine cancer study reveals alarming hemangiosarcoma prevalenceAugust 1, 2023Morris Animal Foundation’s Golden Retriever Lifetime Study has now reached a milestone with the accrual of 500 cumulative diagnoses of four major cancers in dogs: hemangiosarcoma, lymphoma, high-grade mast cell tumor, and osteosarcoma.
Using liquid biopsy for cancer detectionJuly 28, 2023Technology in the form of liquid biopsy is helping us move the needle on early cancer detection in dogs.
Discovering how specialized diets aid inappetence in cancer patientsJuly 26, 2023One of the major issues that can arise during cancer treatment in cats and dogs is malnutrition. Cancer and its treatment often have negative effects on feeding behavior, including loss of appetite. Inability to consume adequate amounts of nutrients and calories can lead to malnutrition and weight loss.
Canine cancer monitoring supported with blood testMay 29, 2023Plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic cancers.
VPN Plus+ ExclusiveIntroduction to Oncology: Easy Peasy BasicsMay 12, 2023This session: Lindsay Hallman, VTS, touches on the history of cancer, and chemotherapy, as well as the modern use of chemotherapy in veterinary medicine. The second half of the lecture focuses on common oncological emergencies, hemangiosarcoma, osteosarcoma, mast cell tumors, and lymphoma.
Pet cancer research campaign to match donationsMay 1, 2023Morris Animal Foundation’s annual pet cancer research campaign just received a funding boost, thanks to a dollar-for-dollar pledge from two industry players.
VPN Plus+ ExclusiveDiagnosing cancer cases in general practice – 'Where do I start?'April 21, 2023Like most medical cases, a systematic approach to diagnosis and treatment is the best place to start. You do not need to know details of prognosis and survival times of every type of cancer to come up with a good diagnostic plan and starting point with your clients.
